SVRA Earnings Date: Nov 11, 2026 (Estimated) — Savara Inc.
NASDAQ
Updated
When is SVRA's next earnings date?
Savara Inc. (SVRA) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 8:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.16 on revenue of $500,000.
How did SVRA do in its last earnings report?
In its most recent report on Aug 11, 2026 (Q2 2026), Savara Inc. posted EPS of -$0.16 versus the -$0.14 estimate, a miss of 14.3%. Revenue was $0 against a $2.0M estimate. The stock's 1-day post-earnings move was +2.3%.
How much does SVRA stock move after earnings?
SVRA beat EPS estimates in 1 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 3.3% (up or down) in the day after earnings.
About Savara Inc.
Savara Inc. is a biopharmaceutical firm in the clinical development phase, specializing in therapies for uncommon respiratory conditions. Their primary investigational drug, molgramostim, is an inhaled form of granulocyte-macrophage colony-stimulating factor (GM-CSF). This compound is currently undergoing Phase III trials to address autoimmune pulmonary alveolar proteinosis. The company's main operations are situated in Austin, Texas.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 | Q2 2026 | -0.14 | -0.16 | -14.29% | $0 | ❌ Miss | +2.33% | -3.59% | -4.49% |
| 2026-05-12 | Q1 2026 | -0.14 | -0.15 | -7.14% | $0 | ❌ Miss | +3.74% | -7.09% | +3.74% |
| 2026-03-13 | Q4 2025 | -0.12 | -0.13 | -8.33% | $0 | ❌ Miss | -1.32% | -3.01% | +11.28% |
| 2025-11-12 | Q3 2025 | -0.13 | -0.14 | -7.69% | $0 | ❌ Miss | -4.85% | -3.70% | +60.28% |
| 2025-08-13 | Q2 2025 | -0.12 | -0.14 | -16.67% | $0 | ❌ Miss | +4.65% | +18.22% | +39.15% |
| 2025-03-27 | Q4 2024 | -0.11 | -0.13 | -18.18% | $0 | ❌ Miss | +2.96% | +11.48% | +17.78% |
| 2024-08-12 | Q2 2024 | -0.11 | -0.12 | -9.09% | $0 | ❌ Miss | +0.98% | +8.54% | +5.37% |
| 2024-03-07 | Q4 2023 | -0.10 | -0.09 | +10.00% | $0 | ✅ Beat | -5.19% | -16.64% | -16.28% |
Showing last 8 quarters.